Leading Russia and CIS focused independent private equity business. 3 funds are under management.
Since 2007, invested in 24 platforms across different industries; over 100 acquisitions , including add ons.
Four primary investment themes:
Consumer goods and services
Healthcare and pharmaceuticals
Ticket size: USD 30-100m (or smaller tickets in case of early stage businesses/experiments)
Average investment horizon: 5 years
Typically acquire control or significant minority stakes in fast growing businesses aiming to
increase scale and improve quality
High quality investment advisory team with unique mix of local and international experience
Investor base consists of top international institutional investors